Thyroid Lobectomy for Unilateral Papillary Thyroid Carcinoma Patients With High‐Volume ( n ≥ 5 ) Central Lymph Node Metastases
Head & Neck · 2026-08 · 48 (8) · 2057-2065
DOI: 10.1002/hed.70217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 06.03.2026. Verfasst von Guixu Lv und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Thyroidectomy, Thyroid Neoplasms, Thyroid Cancer, Papillary. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Background
This study aimed to evaluate whether the extent of thyroidectomy is associated with long‐term prognosis in patients with unilateral papillary thyroid carcinoma (PTC) and high‐volume ( n ≥ 5) central lymph node metastases (CLNM).
Methods
This study retrospectively analyzed the clinicopathological data of patients with unilateral PTC and high‐volume ( n ≥ 5) CLNM who underwent thyroidectomy between January 2013 and December 2019. Patients were divided into the thyroid lobectomy (TL) group and the total thyroidectomy (TT) group based on the extent of thyroidectomy. The primary outcome was recurrence‐free survival (RFS), and the secondary outcome was the incidence of postoperative complications.
Results
A total of 192 patients were included in this study. Among them, 101 patients underwent TL, whereas 91 patients underwent TT. The median follow‐up duration was 60 months. During the follow‐up period, 5 cases of local recurrence were observed among 192 patients. The 5‐year RFS was 97.1% in the TL group and 98.8% in the TT group. The log‐rank test showed no significant difference in RFS between the two groups ( p = 0.672). However, the TT group had higher rates of transient hypoparathyroidism.
Conclusion
TL does not impact the long‐term prognosis in unilateral PTC patients with high‐volume ( n ≥ 5) CLNM. Age ≥ 55 is associated with a higher risk of structure recurrence. For these patients who initially undergo TL, immediate completion thyroidectomy may not be necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, China.
- Department of Hepatobiliary and Vascular Surgery, People's Hospital Affiliated to Shandong First Medical University, Jinan, China.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation of China
Zitieren
APA
Lv, G., Ji, X., Zhao, Q., Ding, C., Liang, W., & Lv, B. (2026). Thyroid Lobectomy for Unilateral Papillary Thyroid Carcinoma Patients With High‐Volume ( n ≥ 5 ) Central Lymph Node Metastases. Head & Neck, 48(8), 2057-2065. https://doi.org/10.1002/hed.70217
Vancouver
Lv G, Ji X, Zhao Q, Ding C, Liang W, Lv B. Thyroid Lobectomy for Unilateral Papillary Thyroid Carcinoma Patients With High‐Volume ( n ≥ 5 ) Central Lymph Node Metastases. Head & Neck. 2026;48(8):2057-2065. doi:10.1002/hed.70217
BibTeX
@article{Lv2026,
author = {Lv, Guixu and Ji, Xiaoyu and Zhao, Qi and Ding, Changyuan and Liang, Weili and Lv, Bin},
title = {Thyroid Lobectomy for Unilateral Papillary Thyroid Carcinoma Patients With High‐Volume ( n ≥ 5 ) Central Lymph Node Metastases},
journal = {Head & Neck},
year = {2026},
volume = {48},
number = {8},
pages = {2057--2065},
doi = {10.1002/hed.70217}
}
EUVIMED